Skip to main content
Top
Published in: Antimicrobial Resistance & Infection Control 1/2024

Open Access 01-12-2024 | Central Venous Catheter | Correspondence

Pseudomonas fluorescens CRBSI outbreak: complying with the standardization of invasive procedures is a step ahead in the fight against antimicrobial resistance

Authors: Patricia Volkow, Tania Guadalupe Chávez-Chávez, Bertha García-Pineda, Consuelo Velázquez-Acosta, Daniel Carpio-Guadarrama, Diana Vilar-Compte, Cyntia Ibanes-Gutiérrez

Published in: Antimicrobial Resistance & Infection Control | Issue 1/2024

Login to get access

Abstract

In the healthcare sector, the implementation of standardized procedures, such as those commonly employed in franchises to ensure consistent quality, remains underprioritized. Within this framework, we focus on the importance of standardized central venous catheter (CVC) insertion procedures to prevent healthcare-associated outbreaks. While antimicrobial resistance (AMR) may still not be the most prevalent problem in some institutions, its increasing significance certainly underlines the urgency of infection prevention.
We aim to highlight this issue by describing and discussing an outbreak scenario of carbapenem-resistant (CR) Pseudomonas fluorescens bloodstream infections resulting from a deviation from the standardized CVC insertion procedure. This outbreak led to six episodes of catheter related bloodstream infection (CRBSI) in patients with hematologic malignancies, delaying their primary treatment. Nineteen patients were exposed, leading to an attack rate of 31.6%.
Literature
2.
go back to reference Volkow P, Sanchez- Mejorada G, de la Vega SL, Vazquez C, Tellez O, Baez RM, et al. Experience of an intravenous therapy team at the Instituto Nacional de Cancerología (Mexico) with a long-lasting, low-cost silastic venous catheter. Clin Infect Dis. 1994;18:719–25.CrossRefPubMed Volkow P, Sanchez- Mejorada G, de la Vega SL, Vazquez C, Tellez O, Baez RM, et al. Experience of an intravenous therapy team at the Instituto Nacional de Cancerología (Mexico) with a long-lasting, low-cost silastic venous catheter. Clin Infect Dis. 1994;18:719–25.CrossRefPubMed
3.
go back to reference Volkow P, Vázquez C, Téllez O, Aguilar C, Barrera L, Rodríguez E, et al. Polyurethane II catheter as long-indwelling intravenous catheter in patients with cancer. Am J Infect Control. 2003;31(7):392–6.CrossRefPubMed Volkow P, Vázquez C, Téllez O, Aguilar C, Barrera L, Rodríguez E, et al. Polyurethane II catheter as long-indwelling intravenous catheter in patients with cancer. Am J Infect Control. 2003;31(7):392–6.CrossRefPubMed
4.
go back to reference Volkow P, Tellez O, Vazquez C, Aguilar C, Valencia M, Barrera L, et al. A single, double lumen high-flow catheter for patients undergoing peripheral blood stem cell transplantation. Experience at the National Cancer Institute in Mexico. Bone Marrow Transplant. 1997;20(9):779–83.CrossRefPubMed Volkow P, Tellez O, Vazquez C, Aguilar C, Valencia M, Barrera L, et al. A single, double lumen high-flow catheter for patients undergoing peripheral blood stem cell transplantation. Experience at the National Cancer Institute in Mexico. Bone Marrow Transplant. 1997;20(9):779–83.CrossRefPubMed
6.
10.
go back to reference Silverio MP, Kraychete GB, Rosado AS, Bonelli RR. Pseudomonas fluorescens complex and its intrinsic, adaptive, and acquired antimicrobial resistance mechanisms in pristine and human-impacted sites. Antibiotics (Basel). 2022;11(8):985.CrossRefPubMed Silverio MP, Kraychete GB, Rosado AS, Bonelli RR. Pseudomonas fluorescens complex and its intrinsic, adaptive, and acquired antimicrobial resistance mechanisms in pristine and human-impacted sites. Antibiotics (Basel). 2022;11(8):985.CrossRefPubMed
11.
go back to reference Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–55.CrossRef Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–55.CrossRef
Metadata
Title
Pseudomonas fluorescens CRBSI outbreak: complying with the standardization of invasive procedures is a step ahead in the fight against antimicrobial resistance
Authors
Patricia Volkow
Tania Guadalupe Chávez-Chávez
Bertha García-Pineda
Consuelo Velázquez-Acosta
Daniel Carpio-Guadarrama
Diana Vilar-Compte
Cyntia Ibanes-Gutiérrez
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Antimicrobial Resistance & Infection Control / Issue 1/2024
Electronic ISSN: 2047-2994
DOI
https://doi.org/10.1186/s13756-024-01390-9

Other articles of this Issue 1/2024

Antimicrobial Resistance & Infection Control 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.